Benedicto-Matambo, P.; Bines, J.E.; Malamba-Banda, C.; Shawa, I.T.; Barnes, K.; Kamng’ona, A.W.; Hungerford, D.; Jambo, K.C.; Iturriza-Gomara, M.; Cunliffe, N.A.;
et al. Leveraging Beneficial Off-Target Effects of Live-Attenuated Rotavirus Vaccines. Vaccines 2022, 10, 418.
https://doi.org/10.3390/vaccines10030418
AMA Style
Benedicto-Matambo P, Bines JE, Malamba-Banda C, Shawa IT, Barnes K, Kamng’ona AW, Hungerford D, Jambo KC, Iturriza-Gomara M, Cunliffe NA,
et al. Leveraging Beneficial Off-Target Effects of Live-Attenuated Rotavirus Vaccines. Vaccines. 2022; 10(3):418.
https://doi.org/10.3390/vaccines10030418
Chicago/Turabian Style
Benedicto-Matambo, Prisca, Julie E. Bines, Chikondi Malamba-Banda, Isaac T. Shawa, Kayla Barnes, Arox W. Kamng’ona, Daniel Hungerford, Kondwani C. Jambo, Miren Iturriza-Gomara, Nigel A. Cunliffe,
and et al. 2022. "Leveraging Beneficial Off-Target Effects of Live-Attenuated Rotavirus Vaccines" Vaccines 10, no. 3: 418.
https://doi.org/10.3390/vaccines10030418
APA Style
Benedicto-Matambo, P., Bines, J. E., Malamba-Banda, C., Shawa, I. T., Barnes, K., Kamng’ona, A. W., Hungerford, D., Jambo, K. C., Iturriza-Gomara, M., Cunliffe, N. A., Flanagan, K. L., & Jere, K. C.
(2022). Leveraging Beneficial Off-Target Effects of Live-Attenuated Rotavirus Vaccines. Vaccines, 10(3), 418.
https://doi.org/10.3390/vaccines10030418